Day One Announces Updated FIREFLY-1 Data for Tovorafenib
Today, Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling New Drug Application (NDA) submission to U.S. Food and Drug Administration (FDA) for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG). Read more
HERE.

April 3, 2026
When Justine Carr laces up her running shoes and crosses the finish line of the Bend Half Marathon this spring, she'll be carrying more than miles in her legs. She'll be carrying the memory of a little girl who danced, told jokes, asked questions, and showed up every single day with a smile that could fill a room. Cameron Corno was Justine's kindergarten student and one of the bravest people Justine has ever known. Cameron passed away on June 6, 2025, after a five-year battle with ependymoma, an aggressive pediatric brain cancer. She was six years old. But in the years since Justine first set her goal to run a race in all 50 states, Cameron's spirit has quietly shaped that mission into something far greater than a personal achievement. Bend, Oregon, will be state #47. And Justine is running it — as she has before — for Cam.


